Get started
Author

Matthew Wells

ANCA Associated Vasculitis Subtypes: Recent Insights and Future Perspectives
2022 · Keziah Austin, Shalini Janagan, et al. · Journal of Inflammation Research · 53
PDF
A multidisciplinary approach to the diagnosis of antisynthetase syndrome
2022 · Matthew Wells, Sughra Alawi, et al. · Frontiers in Medicine · 38
PDF
A systematic review of the role of quantitative CT in the prognostication and disease monitoring of interstitial lung disease
2025 · Giles Dixon, Hannah Thould, et al. · European Respiratory Review · 28
Patient and caregiver shared experiences of pulmonary fibrosis (PF): A systematic literature review
2024 · Matthew Wells, Sam Harding, et al. · Respiratory Medicine · 19
Glofitamab and Epcoritamab in the Real World: A UK Multicentre Retrospective Analysis of Efficacy, Tolerability and Practical Implications
2024 · Euan Haynes, Kushani Ediriwickrema, et al. · Blood · 7
PDF
Patient reported outcomes in systemic vasculitis
2021 · Helena Crawshaw, Matthew Wells, et al. · Current Opinion in Rheumatology · 6
Differences in disease characteristics and outcomes as determined by biological sex in a large UK idiopathic pulmonary fibrosis population: analysis from the British Thoracic Society, Interstitial Lung Disease registry data
2025 · S. Mulholland, G. Dixon, et al. · BMJ Open Respiratory Research · 5
PDF
The pathogenesis, diagnostic utility and clinical relevance of cutaneous telangiectasia in systemic sclerosis
2024 · Aishwarya Anilkumar, Matthew Wells, et al. · Seminars in Arthritis and Rheumatism · 5
PDF
A Retrospective Analysis of 2-Year Follow-Up of Patients with Incidental Findings of Sarcoidosis
2024 · Oluwabukola Thomas-Orogan, Shaney L. Barratt, et al. · Diagnostics · 5
PDF
BEAM-Campath Allogeneic Stem Cell Transplant for Patients with Relapsed/Refractory Lymphoma: High Incidence of Long-Term Mixed Donor-Recipient Chimerism and the Response to Donor Lymphocyte Infusions
2020 · Claire Burney, Karan Wadhera, et al. · Transplantation and Cellular Therapy · 4
Interventions to address supportive care needs of people with pulmonary fibrosis and/or their caregivers: A scoping review
2025 · Naa-Dromoh Quarshie, Matthew Wells, et al. · Palliative Medicine · 3
PDF
Validation of pre-flight algorithms in predicting hypoxic challenge testing (HCT) outcomes in interstitial lung disease (ILD)
2026 · Cameron Bonthrone, Beyazit Durdu, et al. · Therapeutic Advances in Respiratory Disease · 2
Glofitamab and epcoritamab for large B cell lymphoma: a real-world retrospective UK analysis of efficacy, tolerability, and impact of treatment sequencing
2026 · Wendy Osborne, Euan Haynes, et al. · Haematologica · 1
PDF
Analysis of the representation of skin tone diversity amongst medical resources illustrating dermatological manifestations of dermatomyositis, systemic sclerosis and vasculitis
2025 · Stacey Kihumba, Giles Dixon, et al. · Rheumatology Advances in Practice · 1
PDF
ANCA-negative ANCA-associated vasculitis: pitfalls of the ‘vasculitis screen’
2023 · Hannah Cooke, Matthew Wells, et al. · Clinical Medicine · 1
PDF
Monoclonal gammopathy of determined significance—catastrophic lower limb vasculopathy
2021 · Matthew Wells, Hannah Cooke, et al. · Rheumatology · 1
Gastrointestinal manifestation of anti-SAE dermatomyositis
2019 · Matthew Wells, Emma Davies, et al. · Rheumatology · 1
Pleuroparenchymal fibroelastosis in a UK tertiary ILD centre: determinants of radiological progression and survival
2026 · S.L. Barratt, A. Cotton, et al. · Respiratory Medicine
Performance of respiratory patient reported outcome instruments in systemic sclerosis associated interstitial lung disease trials: Are we falling at the first hurdle?
2026 · Matthew Wells, Kirsten Buckley, et al. · Seminars in Arthritis and Rheumatism
Validation of a pre-flight algorithm to guide decision-making on the use of supplemental in-flight oxygen in patients with interstitial lung disease
2026 · Alice Parker, Matthew Wells, et al. · ERJ Open Research
P.187 Influence of BMI, fibromyalgia and migraine on symptom characteristics in people with primary Raynaud’s phenomenon
2026 · Reshma Seomore, Matthew Wells, et al. · Poster presentations
P.206 Cutaneous telangiectasia quantification as a predictive marker of vascular complications of systemic sclerosis
2026 · Matthew Wells, Theresa Smith, et al. · Poster presentations
PDF
The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis
2026 · Matthew Wells, Theresa Smith, et al. · Rheumatology
Influence of comorbidities and patient demographics on Raynaud’s symptom characteristics: implications for diagnosis and management
2026 · Reshma Seomore, Matthew Wells, et al. · Journal of Scleroderma and Related Disorders
Pulmonary cystic destruction in systemic sclerosis and antisynthetase syndrome associated non-specific interstitial pneumonitis: a case series of a novel radiological phenotype
2026 · Matthew Wells, Giles Dixon, et al. · Rheumatology Advances in Practice
Works count: 38
Citation count: 180
H-index: 6
I10-index: 4
Year
Topic
Type